BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Actress Jane Seymour and Insmed Raise Awareness of “Unseenism” and Empower People to Speak Up When It Comes to Their Health

  Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced its involvement with award-winning actress Jane Seymour to raise awareness of gender and age biases in healthcare.

  February 28, 2024

   · 

  4 min read
• Business

  Cue Health to Announce Fourth Quarter and Full Year 2023 Financial Results

  Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024.

  February 28, 2024

   · 

  1 min read
• Business

  Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance

  Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2023 and provided guidance for 2024.

  February 28, 2024

   · 

  39 min read
• Business

  Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance

  Establishment Labs Holdings Inc. (NASDAQ: ESTA) today announced financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance.

  February 28, 2024

   · 

  14 min read
• Business

  Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

  Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2023 and provided a business update.

  February 28, 2024

   · 

  14 min read
• Business

  Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

  Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months and fiscal year ended December 31, 2023.

  February 28, 2024

   · 

  15 min read
• Biotech Bay

  Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw

  Nevro Corp. (NYSE: NVRO) today announced that the U.S. Food and Drug Administration (FDA) cleared its sacroiliac joint fusion device, which will be marketed as Nevro1, without the need to include the screw (“NevroFix™").

  February 28, 2024

   · 

  3 min read
• Business

  Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update

  Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the fourth quarter and full year and provided a business update.

  February 28, 2024

   · 

  20 min read
• Business

  Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update

  Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

  February 28, 2024

   · 

  26 min read
• Business

  Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments

  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2023.

  February 28, 2024

   · 

  44 min read